Bangkok Dusit Medical Services Public (BDMS) Fundamentals 2026 — P/E 19.9x, Revenue Analysis | SniperIQ
Bangkok Dusit Medical Services Public (BDMS) is a TH-listed Healthcare company in Medical - Care Facilities with a market capitalization of ฿309.9B, trading at ฿19.50 on the SET. This SniperIQ fundamentals page covers Bangkok Dusit Medical Services Public's valuation (P/E 19.9x, P/B 2.8x), profitability (net margin 13.9%), revenue (฿111.5B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Bangkok Dusit Medical Services Public's market cap?
Bangkok Dusit Medical Services Public (BDMS) has a market capitalization of approximately ฿309.9B, trading at ฿19.50 on the SET. Market cap moves with the live share price.
What is Bangkok Dusit Medical Services Public's P/E ratio?
Bangkok Dusit Medical Services Public's trailing twelve-month P/E ratio is 19.9x, with a price-to-book (P/B) of 2.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Bangkok Dusit Medical Services Public?
Bangkok Dusit Medical Services Public runs a net profit margin of 13.9%, a gross margin of 35.7%, and an operating margin of 16.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Bangkok Dusit Medical Services Public generate?
Bangkok Dusit Medical Services Public reported revenue of ฿111.5B for fiscal year 2025, with net income of ฿15.8B and earnings per share (EPS) of 1. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Bangkok Dusit Medical Services Public pay a dividend?
Bangkok Dusit Medical Services Public offers a trailing dividend yield of about 5.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Bangkok Dusit Medical Services Public financially healthy?
Bangkok Dusit Medical Services Public carries a debt-to-equity ratio of 0.13x and a current ratio of 1.16x, with a market beta of 0.28. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Bangkok Dusit Medical Services Public a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Bangkok Dusit Medical Services Public (BDMS) the key facts are: market cap ฿309.9B, P/E 19.9x, revenue ฿111.5B, 52-week range 17.4-22.9. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Bangkok Dusit Medical Services Public's full fundamentals live
Get Bangkok Dusit Medical Services Public's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.